Approved
consistent with CDC memo outlining changes to the collection. CDC
will include a warning outlining potential hazards associated with
test samples sent to labs under this collection of
information.
Inventory as of this Action
Requested
Previously Approved
03/31/2010
36 Months From Approved
03/31/2007
2,250
0
900
625
0
175
0
0
0
To support our mission of improving
public health and preventing disease through continuously improving
laboratory practices, the Model Performance Evaluation Program
(MPEP), Division of Laboratory Systems, Public Health Practice
Program Office, Centers for Disease Control and Prevention intends
to provide a new HIV rapid testing performance evaluation program
(HIV Rapid Testing MPEP). This program will offer external
performance evaluation (PE) for rapid tests such as the OraQuick
Rapid HIV-1 Antibody Test, recently approved as a waived test by
the U.S. Food and Drug Administration, and for other licensed tests
such as the Abbott-Murex SUDS HIV-1 Test.
US Code:
42
USC 241 Name of Law: Research and investigations generally
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.